Malaria News and Research

Latest Malaria News and Research

Biomagnetics Diagnostics to accelerate development of assay test cartridge for malaria, HIV/AIDS, hepatitis and TB

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed.

11 Feb 2010

Cerus enters into collaborative agreement with EFS for development of INTERCEPT Blood System

Cerus Corporation announced today that it has entered into a collaborative agreement with France's national transfusion service, the Etablissement Français du Sang (EFS), for the development of the company's INTERCEPT Blood System for red blood cells.

10 Feb 2010

Antimalarial medicines in African countries are substandard, says QAMSA study

The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria.

10 Feb 2010

Findings of poor quality malaria drugs in Africa add to artemisinin-resistance worries

A study released on Monday found that between 26 percent and 44 percent of artemisinin-based malaria drugs sold in Madagascar, Senegal and Uganda "failed quality testing" because of impurities or insufficient amounts of active ingredient, the Associated Press reports.

10 Feb 2010

MSU launches research and training program to address product counterfeiting

Michigan State University has launched the nation's first comprehensive research and training program designed to address product counterfeiting-- which the FBI has called "the crime of the 21st century."

10 Feb 2010

CQ examines concerns over Obama's FY2011 global health budget

Congressional Quarterly examines concerns among health advocates and international development experts about what President Obama's FY 2011 budget request might mean to U.S. commitments to particular diseases abroad, such as HIV/AIDS, tuberculosis and malaria.

9 Feb 2010

Phase 1 trial of Cerus' INTERCEPT red blood system meets primary endpoint

Cerus Corporation announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating that greater than 75 percent of treated cells continued to circulate 24 hours following transfusion. The INTERCEPT red blood cell system is a pathogen inactivation treatment the company is developing to protect against transmission of infectious diseases through red blood cell transfusions. An estimated 70 million units of red blood cells are transfused worldwide each year.

9 Feb 2010

Study indicates women receiving antiretroviral therapy are more likely to become pregnant

In PLoS Medicine this week a study conducted in a multi-country HIV treatment program in sub-Saharan Africa has found that pregnancy rates increase in HIV-infected women after they start antiretroviral therapy (ART).

9 Feb 2010

Breakthrough research could lead to new potential treatments for malaria

Groundbreaking research done at Singapore's Nanyang Technological University's (NTU) School of Biological Sciences (SBS) could lead to the development of more potent drugs or a vaccine for malaria, which is transmitted to humans by infected mosquitoes and kills up to three million people each year.

6 Feb 2010

Research could help in developing protein-based vaccine against maternal malaria

Researchers at the University of Copenhagen have become the first in the world to synthesize the entire protein that is responsible for life-threatening malaria in pregnant women and their unborn children.

5 Feb 2010

Early stage trial finds malaria vaccine effectively protected young children, study says

An experimental vaccine was found to effectively protect young children from malaria in Mali, Reuters reports. According to the news service, "The vaccine, which uses an immune system booster called an adjuvant from British drugmaker GlaxoSmithKline, targets the malaria parasite as it is actively infecting red blood cells and causing fever and illness" (Steenhuysen, 2/3).

5 Feb 2010

Global cancer rates could be reduced by 40% with prevention strategies, report says

"Forty percent of the 12 million people diagnosed with cancer worldwide each year could avert the killer disease by protecting themselves against infections and changing their lifestyles, experts said on Tuesday," Reuters reports.

4 Feb 2010

Scientists identify potential drug therapy target for malaria

Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells.

4 Feb 2010

Findings provide potential new targets to combat malaria

Yale University researchers have found more than two dozen scent receptors in malaria-transmitting mosquitoes that detect compounds in human sweat, a finding that may help scientists to develop new ways to combat a disease that kills 1 million people annually.

4 Feb 2010

New vaccine to prevent malaria infection shown promise to protect young children

A new vaccine to prevent the deadly malaria infection has shown promise to protect the most vulnerable patients - young children - against the disease, according to an international team of researchers led by the University of Maryland School of Medicine's Center for Vaccine Development (CVD) and the Malaria Research and Training Center at the University of Bamako in Mali, West Africa.

4 Feb 2010

Malaria News and Research

Latest Malaria News and Research

Biomagnetics Diagnostics to accelerate development of assay test cartridge for malaria, HIV/AIDS, hepatitis and TB

Cerus enters into collaborative agreement with EFS for development of INTERCEPT Blood System

Antimalarial medicines in African countries are substandard, says QAMSA study

Findings of poor quality malaria drugs in Africa add to artemisinin-resistance worries

MSU launches research and training program to address product counterfeiting

CQ examines concerns over Obama's FY2011 global health budget

Phase 1 trial of Cerus' INTERCEPT red blood system meets primary endpoint

Study indicates women receiving antiretroviral therapy are more likely to become pregnant

Breakthrough research could lead to new potential treatments for malaria

Research could help in developing protein-based vaccine against maternal malaria

Early stage trial finds malaria vaccine effectively protected young children, study says

Global cancer rates could be reduced by 40% with prevention strategies, report says

Scientists identify potential drug therapy target for malaria

Findings provide potential new targets to combat malaria

New vaccine to prevent malaria infection shown promise to protect young children

New study to investigate preventative programmes for anaemia control in young women

Insecticide-treated bed-nets can help in preventing malaria

Obama's FY 2011 budget gives global health funding boost

African leaders discuss ways to achieve universal malaria control measures deadline

HHS appoints new members to Presidential Advisory Council on HIV/AIDS

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Malaria News and Research

Latest Malaria News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in